A Mucinous Histochemical Study on Malignancy of Aberrant Crypt Foci (ACF) in Rat Colon

Journal of Veterinary Medical Science

Volumn 63, Issue 2, 2001, Pages 145-149

  Uchida, Kazumi ^a   Kado, Shoichi ^a   Ando, Minoru ^a   Nagata, Yuriko ^a   Takagi, Akimitsu ^a   Onoue, Masaharu ^a  

^a YAKULT CENTRAL INSTITUTE FOR MICROBIOLOGICAL RESEARCH   (Japan)

Author keywords

Aberrant crypt foci; Goblet cell mucin; Paradoxical concanavalin A staining; Rat colon

Indexed keywords

MUCIN; SIALOMUCIN; SULFOMUCIN;

ANIMAL; ARTICLE; COLLOID CARCINOMA; COLON TUMOR; CYTOCHEMISTRY; CYTOLOGY; GOBLET CELL; MALE; METABOLISM; PATHOLOGY; PRECANCER; RAT;

ADENOCARCINOMA, MUCINOUS; ANIMALS; COLONIC NEOPLASMS; GOBLET CELLS; HISTOCYTOCHEMISTRY; MALE; MUCINS; PRECANCEROUS CONDITIONS; RATS; SIALOMUCINS;

EID: 0035259748     PISSN: 09167250     EISSN: None     Source Type: Journal    
DOI: 10.1292/jvms.63.145     Document Type: Article

References (32)

1. Bird, R. P. 1987. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: Preliminary findings. Cancer Lett. 37: 147-151.
2. Bird, R. P. 1995. Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Res. 93: 55-71.
3. Carraro, S., Hamamura, S., Tiscornia, O., Celener, D., Celener, F. G. and Fernandez, L. B. 1993. Ulex Europeus agglutinin I binding pattern during chemical carcinogenesis in the rat gastrointestinal tract. Cancer 72: 669-676.
4. Dawson, P. A., Patel, J. and Filipe, M. I. 1978. Variations in sialomucins in the mucosa of the large intestine in malignancy: A quantimet and statistical analysis. Histochem. J. 10: 559-572.
5. Filipe, M. I. 1969. Value of histochemical reactions for mucosubstances in the diagnosis of certain pathological conditions of the colon and rectum. Gut 10: 577-586.
6. Filipe, M. I. 1975. Mucous secretion in rat colonic mucosa during carcinogenesis induced by dimethylhydrazine. A morphological and histiochemical study. Br. J. Cancer 32: 60-77.
7. Jass, J. R., Allison, L. J., Stewart, S. M. and Lane, M. R. 1993. Ulex europaeus agglutinin-1 binding in hereditary bowel cancer. Pathology 25: 114-119 .
8. Jen, J., Powell, S. M., Papadopoulos, N., Smith, K. J., Hamilton, S. R., Vegelstein, B. and Kinzler, K. W. 1994, Molecular determinants of dysplasia in colorectal lesions. Cancer Res. 54: 5523-5526.
9. Katsuyama, T. and Spicer, S. 1978. Histochemical differentiation of complex carbohydrates with variants of the concanavalin A-horseradish peroxidase method. J. Histochem. Cytochem. 26: 233-250.
10. Kristiansen, E. 1996. The role of aberrant crypt foci induced by the two heterocyclic amines 2-amino-3-methyl-imidazo [4,5-f] quinoline (IQ) and 2-amino-1-methyl-6-phenyl-imidazo [4,5-b] pyridine (PhIP) in the development of colon cancer in mice. Cancer Lett. 110: 187-192.
11. Lev, R. 1968. A histochemical study of glycogen and mucin in developing human foetal epithelia. Histochem. J. 1: 152-165.
12. Matsushita, Y., Yamamoto, N., Shirahama, H., Tanaka, S., Yonezawa, S., Yamori, T., Irimura, T. and Sato, E. 1995. Expression of sulfomucins in normal mucosae, colorectal adenocarcinomas, and metastases. Jpn. J. Cancer Res. 86: 1060-1067.
13. McLellan, E. A., Medline, A. and Bird, R. P. 1991. Sequential analyses of the growth and morphological characteristics of aberrant crypt foci: Putative preneoplastic lesions. Cancer Res. 51: 5270-5274.
14. Nakamura, T., Yonezawa, S., Tanaka, S. and Sato, E. 1985. Lectin histochemistry in colorectal adenomas and early carcinomas. Pathol. Clin. Med. 3: 317-322 (in Japanese).
15. Otori, K., Sugiyama, K., Hasebe, T., Fukushima, S. and Esumi, H. 1995. Emergence of adenomatous aberrant crypt foci (ACF) from hyperplastic ACF with concomitant increase in cell proliferation. Cancer Res. 55: 4743-4746.
16. Pretlow, T. P., Brasitus, T. A., Fulton, N. C., Cheyer, C. and Kaplan, E. L. 1993. K-ras mutation in putative preneoplastic lesions in human colon. J. Natl. Cancer Inst. 85: 2004-2007.
17. Pretlow, T. P., O'Riordan, M. A., Somich, G. A., Amini, S. B. and Pretlow, T. G. 1992. Aberrant crypts correlate with tumor incidence in F344 rats treated with azoxymethane and phytate. Carcinogenesis 13: 1509-1512.
18. Pretlow, T. P., Roukhadze, E. V., O'Riordan, M. A., Chan, J. C., Amini, S. B. and Stellato, T. A. 1994. Carcinoembryonic antigen in human colonic aberrant crypt foci. Gastroenterology 107: 1719-1725.
19. Roncucci, L., Stamp, D., Medline, A., Cullen, J. B. and Bruce, W. R. 1991. Identification and quantification of aberrant crypt foci and microadenomas in the human colon. Hum. Pathol. 22: 287-294.
20. Sandforth, F., Heimpel, S., Balzer, T., Gutschmidt, S. and Riecken, E. O. 1988. Characterization of stereomicroscopically identified preneoplastic lesions during dimethylhydrazine-induced colonic carcinogenesis. Eur. J. Clin. Invest. 18: 655-662.
21. Shivapurkar, N., Tang, Z., Ferreira, A., Nasim, S., Garett, C. and Alabaster, O. 1994. Sequential analysis of K-ras mutation in aberrant crypt foci and colonic tumors induced by azoxymethane in Fischer-344 rats on high-risk diet. Carcinogenesis 15: 775-778.
22. Shpitz, B., Bomstein, Y., Cohen, Y., Kaufman, Z., Neufeld, D., Galkin, M. and Bernheim, J. 1998. Aberrant crypt foci in human colons: Distribution and histomorphologic characteristics. Human Pathol. 29: 469-475.
23. Siu, I-M., Pretlow, T. G., Amini, S. B. and Pretlow, T. P. 1997. Identification of dysplasia in human colonic aberrant crypt foci. Am. J. Pathol. 150: 1805-1813.
24. Smith, A. J., Stern, H. S., Kazy, M. P., Mitri, H. A., Bapat, B. V. and Gallinger, S. 1994. Somatic APC and K-ras codon 12 mutation in aberrant crypt foci from human colons. Cancer Res. 54: 5527-5530.
25. Stopera, S. A., Murphy, L. C. and Bird, R. P. 1992. Evidence for a ras gene mutation in azoxymethane-induced colonic aberrant crypts in Sprague-Dawley rats: Earliest recognizable precursor lesion of experimental colon cancer. Carcinogenesis 13: 2081-2085.
26. Takemiya, M., Miyayama, H. and Takeuchi, T. 1982. Pathogenesis of 1,2-dimethylhydrazine-induced carcinomas in rat intestine II. Histochemical and ultrastructural characteristics of glycoproteins of 1,2-dimethylhydrazine-induced carcinoma cells. Acta Pathol. Jpn. 32: 265-279.
27. Tatematsu, M., Katsuyama, T., Nakanowatari, J., Hasegawa, R., Imaida, K., Fukushima, S. and Ito, S. 1982. Region-specific patterns of mucin reaction demonstrated by paradoxical concanavarin A-staining in normal colonic epithelium and in colorectal cancers induced in rats by 1,2-dimethylhydrazine. Gann 73: 77-84.
28. Uchida, K., Kado, S., Onoue, M. and Tohyama, K. 1997. Relationship between the nature of mucus and crypt multiplicity in aberrant crypt foci in the rat colon. Jpn. J. Cancer Res. 88: 807-814.
29. Yamachika, T., Nakanishi, H., Inada, K., Kitoh, K., Kato, T., Irimura, T. and Tatematsu, M. 1997. Reciprocal control of colon-specific sulfomucin and sialosyl-Tn antigen expression in human colorectal neoplasia. Virchows Arch. 431: 25-30.
30. Yamashita, N., Minamoto, T., Ochiai, A., Onda, M. and Esumi, H. 1995. Frequent and characteristic K-ras activation and absence of p53 protein accumulation in aberrant crypt foci of the colon. Gastroenterology 108: 434-440.
31. Yonezawa, S., Nakamura, T., Tanaka, S. and Sato, E. 1982. Glycoconjugate with Ulex europaeus agglutinin-I-binding sites in normal mucosa, adenoma, and carcinoma of the human large bowel. J. Natl. Cancer Inst. 69: 777-785.
32. Zusman, I., Zimber, A. and Nyska, A. 1991. Role of morphological methods in the analysis of chemically induced colon cancer in rats. Acta Anat. 142: 351-356.